We Are Underprepared for Bedaquiline Resistance: A Call for Clinical and Programmatic Readiness. [PDF]
Cross GB, Walker HN, Hasan T, Berry C.
europepmc +1 more source
A novel antituberculosis agent exhibits potent clinical efficacy and good safety profile: an open-label, randomized-controlled, multicenter, phase 2a trial. [PDF]
Chu N +15 more
europepmc +1 more source
Increasing Antimicrobial Resistance to First-Line Therapies in Chronic Endometritis: A 2020-2024 Cross-Sectional Study. [PDF]
Cicinelli E +10 more
europepmc +1 more source
Antibiotic Class-Specific Effects on Inflammatory Bowel Disease: Microbiome Disruption, Risk, and Recovery. [PDF]
Rajarathinam B +12 more
europepmc +1 more source
<i>In vitro</i> exposure to clofazimine can select for delamanid and pretomanid resistance in <i>Mycobacterium tuberculosis</i>. [PDF]
Rupasinghe P +15 more
europepmc +1 more source
Pneumonia with parapneumonic effusion due to <i>Fusobacterium necrophorum</i>: a case report. [PDF]
Dong X, Li Q, Zhu A, Wu X, Wu X.
europepmc +1 more source
Detection Blind Spots in Microbial Culture, tNGS, and mNGS: Anaerobic Bacterial Infections in the Lung-A Retrospective Analysis of Two Cases. [PDF]
Zhuang J +7 more
europepmc +1 more source
Designing the Next Generation of Antibiotics: Structure, SAR, and Strategy in Medicinal Chemistry (2000-2025). [PDF]
Al-Karmalawy AA +6 more
europepmc +1 more source
[From ICU to recovery: recurrent pneumonia due to Lophomonas blattarum]. [PDF]
Cárdenas-de Luna MJ +4 more
europepmc +1 more source

